Bogotá - Medicina - Maestría en Genética Humana · 2024
Análisis de variantes genéticas en una familia con diagnóstico clínico de cáncer hereditario de síndrome de Li-Fraumeni like mediante panel de secuencia de nueva generación
Li-Fraumeni syndrome is one of the hereditary cancer syndromes that account for 5-10% of all cancers and is related to pathogenic variants inherited within family, increasing the risk of cancer significantly. It has an approximate prevalence of 1:3,555 to 1:5,476 people worldwide, with high interregional variability. In Colombia, this information is unknown. The disease occurs in two clinical forms: classic Li-Fraumeni syndrome (LFS) and Li-Fraumeni-like syndrome (LFL), which have different clinical classification criteria. In LFL, the prevalence of germline variants in the TP53 gene is lower, and its occurrence is likely related to other altered genes. Detection rates for TP53 variants range from 55% to 70% when classical classification criteria are met, 25% to 30% for LFL criteria, and 20% to 35% for Chompret criteria. This means that up to 45% of patients meeting classical LFS criteria and up to 80% of patients meeting either Chompret or LFL criteria remain genetically unexplained. The aim of this study was to characterize germline genetic variants in a family with a clinical diagnosis of hereditary LFL cancer using a whole-exome-expanded next-generation sequencing (NGS) panel in the index case. No pathogenic, likely pathogenic or uncertain clinical significance (VUS) variants were identified in the TP53 gene or any of the candidate genes linked to the FL phenotype. Possible unevaluated mechanisms that could contribute to the phenotype include methylation of TP53 promoter regions, deep intronic variants or variants in TP53 regulatory regions, and alterations in the expression of TP53 isoforms. Therefore, additional studies should be performed to provide an explanation for the occurrence of this familial phenotype.
Texto completo 50 páginas con texto
Leer la tesis completa Ficha en el repositorio
Contenido
- Marco Teóricop. 13
- 4.1 Cáncer hereditariop. 13
- 4.2 Síndromes de cáncer hereditariop. 13
- 4.3 Síndrome de Li-Fraumenip. 15
- 4.4 Gen TP53p. 16
- 4.5 Metilación de TP53p. 18
- 4.6 Otros genes asociados al síndrome de Li-Fraumenip. 19
- 4.7 Criterios clínicos diagnósticos del LFSp. 20
- 4.8 Análisis por secuencia de nueva generación (NGS)p. 23
- 4.9 Panorama en Colombiap. 24
- Metodologíap. 26
- 5.1 Tipo de investigaciónp. 26
- 5.2 Descripción de los pacientesp. 26
- 5.3 Extracción de DNA, cuantificación y verificación de calidadp. 29
- 5.4 Panel genético de 111 genes relacionados con cáncerp. 29
- 5.5 Exoma completo individuo índicep. 31
- 5.6 Exoma dirigido: 157 genes relacionados con cáncer en caso índicep. 31
- Resultadosp. 33
- 6.1 Verificación de calidadp. 33
- 6.2 Análisis Panel de 111 Genesp. 36
- 6.3 Análisis de Exoma Completo en Individuo F9p. 37
- 6.4 Panel Dirigido de 157 Genes en Individuo F9p. 37
- Discusiónp. 39
- Conclusionesp. 42
- Recomendacionesp. 43
- 10. Bibliografíap. 44